Enhanced efficacy of combined HDAC and PARP targeting in glioblastoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhanced efficacy of combined HDAC and PARP targeting in glioblastoma
Authors
Keywords
-
Journal
Molecular Oncology
Volume 10, Issue 5, Pages 751-763
Publisher
Wiley
Online
2016-01-09
DOI
10.1016/j.molonc.2015.12.014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthetic Lethality and Cancer Therapy: Lessons Learned from the Development of PARP Inhibitors
- (2015) Christopher J. Lord et al. Annual Review of Medicine
- The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence
- (2015) Brenda Auffinger et al. Expert Review of Neurotherapeutics
- Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma
- (2015) Melissa M. Singh et al. NEURO-ONCOLOGY
- Acquisition of meiotic DNA repair regulators maintain genome stability in glioblastoma
- (2015) M Rivera et al. Cell Death & Disease
- The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence
- (2015) Brenda Auffinger et al. Expert Review of Neurotherapeutics
- Histone deacetylase inhibitor treatment induces ‘BRCAness’ and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells
- (2015) Kyungsoo Ha et al. Oncotarget
- Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer
- (2014) Panagiotis A. Konstantinopoulos et al. GYNECOLOGIC ONCOLOGY
- ATR inhibition preferentially targets homologous recombination-deficient tumor cells
- (2014) M Krajewska et al. ONCOGENE
- Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe
- (2014) M Cornago et al. Cell Death & Disease
- Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells
- (2013) M Venere et al. CELL DEATH AND DIFFERENTIATION
- γH2AX foci formation in the absence of DNA damage: Mitotic H2AX phosphorylation is mediated by the DNA-PKcs/CHK2 pathway
- (2013) Wen-Zhi Tu et al. FEBS LETTERS
- SAHA Enhances Synaptic Function and Plasticity In Vitro but Has Limited Brain Availability In Vivo and Does Not Impact Cognition
- (2013) Jesse E. Hanson et al. PLoS One
- Malignant Glioma: Lessons from Genomics, Mouse Models, and Stem Cells
- (2012) Jian Chen et al. CELL
- Novel therapeutic agents for cutaneous T-Cell lymphoma
- (2012) Salvia Jain et al. Journal of Hematology & Oncology
- An epigenetic blockade of cognitive functions in the neurodegenerating brain
- (2012) Johannes Gräff et al. NATURE
- Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?
- (2012) Shota Tanaka et al. Nature Reviews Clinical Oncology
- BRCAness: Finding the Achilles Heel in Ovarian Cancer
- (2012) G. Rigakos et al. ONCOLOGIST
- Molecular subclassification of diffuse gliomas: Seeing order in the chaos
- (2011) Jason T. Huse et al. GLIA
- Vorinostat modulates cell cycle regulatory proteins in glioma cells and human glioma slice cultures
- (2011) Jihong Xu et al. JOURNAL OF NEURO-ONCOLOGY
- Tracking genome engineering outcome at individual DNA breakpoints
- (2011) Michael T Certo et al. NATURE METHODS
- Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors
- (2011) M. M. Singh et al. NEURO-ONCOLOGY
- Vorinostat Induces Reactive Oxygen Species and DNA Damage in Acute Myeloid Leukemia Cells
- (2011) Luca A. Petruccelli et al. PLoS One
- Loss of ATM/Chk2/p53 Pathway Components Accelerates Tumor Development and Contributes to Radiation Resistance in Gliomas
- (2010) Massimo Squatrito et al. CANCER CELL
- Radiographic patterns of relapse in glioblastoma
- (2010) Marc C. Chamberlain JOURNAL OF NEURO-ONCOLOGY
- Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas
- (2010) J Bartkova et al. ONCOGENE
- Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor
- (2010) Sushant K. Kachhap et al. PLoS One
- The role of BRCA1 in DNA damage response
- (2010) Jiaxue Wu et al. Protein & Cell
- Synthetic lethal targeting ofPTENmutant cells with PARP inhibitors
- (2009) Ana M. Mendes-Pereira et al. EMBO Molecular Medicine
- Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
- (2009) Evanthia Galanis et al. JOURNAL OF CLINICAL ONCOLOGY
- Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90
- (2009) F. A. Dungey et al. MOLECULAR CANCER THERAPEUTICS
- Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors
- (2008) Jung-Hyun Park et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue: class II and IV are hypoexpressed in glioblastomas
- (2008) Agda KB Lucio-Eterovic et al. BMC CANCER
- Replication-Dependent Radiosensitization of Human Glioma Cells by Inhibition of Poly(ADP-Ribose) Polymerase: Mechanisms and Therapeutic Potential
- (2008) Fiona A. Dungey et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now